Document:

<PAGE>

                                                                     Exhibit 4.2

                                CYTRX CORPORATION
                             154 Technology Parkway
                             Norcross, Georgia 30092

                                February 11, 2002

American Stock Transfer & Trust Company
40 Wall Street
New York, New York 10005
Attention: Corporate Trust Department

Re:   Amendment No. 1 to Shareholder Protection Rights Agreement dated as of
      April 16, 1997 (the "Rights Agreement") between CytRx Corporation
      ("CytRx") and American Stock Transfer & Trust Company ("AST")

Ladies and Gentlemen:

Pursuant to Section 5.4 of the Rights Agreement, CytRx, by resolution
adopted by its board of directors, hereby amends the Rights Agreement as
follows:

1. The definition of "Acquiring Person" in Section 1.1 of the Rights
Agreement is hereby deleted and replaced in its entirety with the following:

"Acquiring Person" shall mean any Person who is a Beneficial Owner of 15% or
more of the outstanding shares of Common Stock; provided, however, that the
term "Acquiring Person" shall not include any Person (i) who is the Beneficial
Owner of 15% or more of the outstanding shares of Common Stock on the date of
this Agreement or who shall become the Beneficial Owner of 15% or more of the
outstanding shares of Common Stock solely as a result of an acquisition by the
Company of shares of Common Stock, until such time hereafter or thereafter as
any of such Persons shall become the Beneficial Owner (other than by means of
stock dividend or stock split) of any additional shares of Common Stock, (ii)
who, on or after the date of this Agreement, is or shall become the Beneficial
Owner of 15% or more of the outstanding shares of Common Stock (or securities
convertible into, exchangeable into or exercisable for Common Stock) pursuant to
the Agreement and Plan of Merger dated as of February 11, 2002 (the "Merger
Agreement") among the Company, Global Genomics Capital, Inc. and GGC Merger
Corporation or the Merger (as defined in the Merger Agreement or other
transactions contemplated by the Merger Agreement, until such time hereafter or
thereafter as such Person shall become the Beneficial Owner (other than (1) by
means of a stock dividend, stock split or other similar event or (2) pursuant to
the exercise of any stock option granted by the Company's board of directors or
compensation committee on or after the date of this Agreement to such Person in
such Person's capacity as an officer or

<PAGE>

director of the Company) of any additional shares of Common Stock, (iii) who
is the Beneficial Owner of 15% or more of the outstanding shares of Common
Stock but who acquired Beneficial Ownership of shares of Common Stock without
any plan or intention to seek or affect control of the Company, if such Person
promptly enters into an irrevocable commitment promptly to divest, and
thereafter promptly divests (without exercising or retaining any power,
including voting power, with respect to such shares), sufficient shares of
Common Stock (or securities convertible into, exchangeable into or exercisable
for Common Stock) so that such Person ceases to be the Beneficial Owner of 15%
or more of the outstanding shares of Common Stock or (iv) who Beneficially Owns
shares of Common Stock consisting solely of one or more of (A) shares of Common
Stock Beneficially Owned pursuant to the grant or exercise of an option granted
to such Person by the Company in connection with an agreement to merge with, or
acquire, the Company entered into prior to a Flip-In Date, (B) shares of Common
Stock (or securities convertible into, exchangeable into or exercisable for
Common Stock) acquired by Affiliates or Associates of such Person after the time
of such grant which, in the aggregate, amount to less than 1% of the outstanding
shares of Common Stock. In addition, the Company, any wholly owned Subsidiary of
the Company and any employee stock ownership or other employee benefit plan of
the Company or a wholly owned Subsidiary of the Company shall not be an
Acquiring Person.

2. The definition of "Stock Acquisition Date" in Section 1.1 of the
Rights Agreement is hereby amended by adding the following sentence to the
end thereof:

"Neither the Merger Agreement nor the Merger or any other transaction
contemplated thereby shall cause a Stock Acquisition Date."

3. The definition of "Separation Time" in Section 1.1 of the Rights
Agreement is hereby amended by adding the following sentence to the end thereof:

"Neither the Merger Agreement nor the Merger or any other transaction
contemplated thereby shall cause a Separation Time."

4. Section 5.4 of the Rights Agreement is hereby amended by adding the
following sentence to the end thereof:

"Notwithstanding the above, from the Effective Time (as defined in the
Merger Agreement) until the second anniversary thereof, no amendment or
supplement may be made to this Agreement, and no such amendment or supplement
shall be effective, without the prior approval of a majority of the
then-disinterested members of the Company's board of directors."

5. Except as expressly amended hereby, the Rights Agreement shall
remain in full force and effect.

<PAGE>

6.  Capitalized terms used herein and not otherwise defined herein shall have
the meaning ascribed to them in the Rights Agreement.

7. This Amendment No. 1 shall be governed by and construed in accordance with
the laws of the State of Delaware, without regard to the conflicts of
law principles thereof.

8. This Amendment No. 1 may be executed in any number of counterparts and
each of such counterparts shall be deemed to be an original and all of which
together shall be deemed to be one and the same agreement.

9. This Amendment No. 1 to the Rights Agreement shall be effective as of the
date hereof, and all references to the Rights Agreement shall, from and
after such time, be deemed to be references to the Rights Agreement as amended
hereby.

                                                Very truly yours,

                                                CytRx Corporation

                                                By: /s/ Jack J. Luchese
                                                    ----------------------
                                                Name: Jack J. Luchese
                                                     ---------------------
                                                Title: President & CEO
                                                      --------------------

Accepted and agreed to as of the date first written above:

American Stock Transfer & Trust Company

By: /s/ Herbert J. Lemmer
   --------------------------
Name: Herbert J. Lemmer
     ------------------------
Title: Vice President
      -----------------------<PAGE>

                                                                    Exhibit 10.4

                     AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT
                              with Jack J. Luchese

This AMENDMENT No. 1 (the "Amendment"), effective as of January 1, 2002, by and
between CytRx Corporation, a Delaware corporation (the "Company"), and Jack J.
Luchese ("Mr. Luchese"), amends that certain Amended and Restated Employment
Agreement, dated as of September 1, 1999, by and between the Company and Mr.
Luchese (the "Employment Agreement").

In consideration of the mutual promises and covenants herein contained, the
parties hereto agree as follows:

1. The caption of Section 3 of the Employment Agreement is hereby renamed
"Compensation" and new subsections 3(c), 3(d) and 3(e) of the Employment
Agreement are hereby added, to read as follows:

"(c) Success Bonus. If either of the following two events shall occur prior to
     -------------
the termination of this Agreement for any reason: (i) the execution by the
Company of a definitive agreement for a transaction that, if consummated, would
constitute a Change of Control under Section 2(c) of that certain Amended and
Restated Change in Control Employment Agreement, dated as of September 1, 1999,
as amended, by and between the Company and Mr. Luchese (the "Change in Control
Agreement"); or (ii) the execution by the Company of a FLOCOR license agreement
for sickle cell disease (each such event being referred to as a "Milestone
Event"), the Company shall pay to Mr. Luchese a success bonus equal to $435,150
(the "Success Bonus"). The Success Bonus shall be paid in a lump sum in cash as
soon as practicable after the occurrence of the applicable Milestone Event. The
Success Bonus is subject to forfeiture as provided in Section 3(e) below.

(d) Change in Control Payment. If, prior to the termination of this Agreement
    -------------------------
for any reason, the stockholders of the Company approve a transaction that, if
consummated, would constitute a Change of Control under Section 2(c) of the
Change in Control Agreement, or if a Change of Control (as defined in the Change
in Control Agreement) is consummated during such period regardless of
stockholder approval, the Company shall pay to Mr. Luchese, or his estate, in a
lump sum in cash as soon as practicable after the occurrence of such event the
higher of (i) $870,300, or (ii) the amount equal to two (2) times the sum of (A)
Mr. Luchese's annual salary as in effect immediately prior to the occurrence of
such event, plus (B) the amount of Mr. Luchese's highest annual bonus for the
last three full fiscal years prior to the occurrence of such event (such higher
amount being referred to herein as the "Change in Control Payment"); provided,
however, that the Change in Control Payment shall be reduced by the amount, if
any, of the Success Bonus previously paid to Mr. Luchese under Section 3(c) of
this Agreement. The Change in Control Payment is subject to forfeiture as
provided in Section 3(e) below.

(e) Forfeiture of Benefits. Notwithstanding any provision of this Agreement to
    ----------------------
the contrary, Mr. Luchese shall forfeit his right to receive, or, to the extent
such amounts have previously been paid to him, shall repay in full to the
Company with interest at 8% per annum

<PAGE>

within thirty (30) days of a final determination of his liability therefor as
set forth below, the Success Bonus (as defined in Section 3(c) above) and the
Change in Control Payment (as defined in Section 3(d) above) if at any time
during the period of two years after the termination of his employment (the
"Restricted Period") he violates the restrictions on competition set forth in
Section 10 hereof. Any determination of whether Mr. Luchese has violated such
non-competition restrictions shall be made by arbitration in Atlanta, Georgia
under the Rules of Commercial Arbitration (the "Rules") of the American
Arbitration Association, which Rules are deemed to be incorporated by reference
herein."

2. A new subsections 7(d) of the Employment Agreement is hereby added, to read
as follows:

"(d) Reduction of Severance Benefits. Notwithstanding any provision of this
     -------------------------------
Agreement to the contrary, any rights Mr. Luchese may have under this Section 7
to a continuation of salary after his termination of employment shall be
reduced (but not below zero) by the amount, if any, he receives of the Success
Bonus (as defined in Section 3(c) above) and/or the Change in Control Payment
(as defined in Section 3(d) above)."

3. As amended hereby, the Employment Agreement shall be and remain in full force
and effect.

IN WITNESS WHEREOF, Mr. Luchese has hereunto set his hand and, pursuant to the
authorization from its Board of Directors, the Company has caused this
Agreement to be executed in its name on its behalf by its undersigned officer
thereunto, duly authorized, all as of the day and year first above written.

                                 /s/ Jack J. Luchese
                                 ---------------------------------
                                 Jack J. Luchese

Attest:                          CYTRX CORPORATION:

/s/ Mark W. Reynolds             /s/ William B. Fleck
---------------------            -----------------------------------
Corporate Secretary              By:      William B. Fleck
(CORPORATE SEAL)                 Title:   Vice President, Human Resources

                                 /s/ Herbert H. McDade, Jr.
                                 ------------------------------------
                                 By:      Herbert H. McDade, Jr.
                                 Title:   Chairman, CytRx Compensation Committee

                                        2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}]]